Kerrii B. Anderson net worth and biography

Kerrii Anderson Biography and Net Worth

Kerrii B. Anderson has served as a director of the Company since May 17, 2006. Ms. Anderson is the former Chief Executive Officer, President and Chief Financial Officer of Wendy’s International. Prior to joining Wendy’s in 2000, she was senior vice president and chief financial officer for 14 years for M/I Schottenstein Homes, Inc., a NYSE company that builds single-family homes.

Ms. Anderson has served as a director of Abercrombie & Fitch Co. since February 2018, The Sherwin-Williams Company since April 2019, and Worthington Industries, Inc. since September 2010. She was previously a director of the board of Chiquita Brands International from 2009 to 2012, and was chairwoman of the board from 2012 until the company’s acquisition in 2015. She was also a member of the board of P.F. Chang’s China Bistro from 2009 to 2012. Ms. Anderson also serves on the boards of the following non-profit entities: The Columbus Foundation, Ohio Health Board of Trustees and Elon University Board of Trustees.

Ms. Anderson has a strong record of leadership in operations, strategy, finance and talent management as a result of her experience at Wendy’s. Ms. Anderson also has significant expertise in the areas of accounting and financial reporting, corporate finance, corporate governance, and executive compensation through her service on other large public company boards. The breadth of experience enables Ms. Anderson to advise our Board on a variety of matters related to global operations and business strategy.

What is Kerrii B. Anderson's net worth?: The estimated net worth of Kerrii B. Anderson is at least $9.10 million as of March 8th, 2024. Ms. Anderson owns 45,878 shares of Laboratory Co. of America stock worth more than $9,102,195 as of April 27th. This net worth approximation does not reflect any other investments that Ms. Anderson may own. Learn More about Kerrii B. Anderson's net worth.
How do I contact Kerrii B. Anderson?: The corporate mailing address for Ms. Anderson and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Kerrii B. Anderson's contact information.
Has Kerrii B. Anderson been buying or selling shares of Laboratory Co. of America?: Kerrii B. Anderson has not been actively trading shares of Laboratory Co. of America within the last three months. Most recently, Kerrii B. Anderson sold 5,000 shares of the business's stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $211.57, for a transaction totalling $1,057,850.00. Following the completion of the sale, the director now directly owns 15,275 shares of the company's stock, valued at $3,231,731.75. Learn More on Kerrii B. Anderson's trading history.
Who are Laboratory Co. of America's active insiders?: Laboratory Co. of America's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Brian Caveney (EVP), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.
Are insiders buying or selling shares of Laboratory Co. of America?: During the last year, insiders at the medical research company sold shares 14 times. They sold a total of 66,701 shares worth more than $14,419,280.01. The most recent insider tranaction occured on April, 1st when COO Mark S Schroeder sold 6,477 shares worth more than $1,407,387.33. Insiders at Laboratory Co. of America own 0.9% of the company. Learn More about insider trades at Laboratory Co. of America.
Information on this page was last updated on 4/1/2024.

Kerrii B. Anderson Insider Trading History at Laboratory Co. of America

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/8/2023	Sell	5,000	$211.57	$1,057,850.00	15,275
9/23/2019	Sell	2,600	$171.85	$446,810.00
6/20/2019	Sell	3,100	$170.00	$527,000.00	22,233
11/5/2018	Sell	3,700	$163.29	$604,173.00	21,795

Kerrii B. Anderson Buying and Selling Activity at Laboratory Co. of America

Laboratory Co. of America Company Overview

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Today's Range

Now: $198.40

$197.01

$200.16

50 Day Range

MA: $211.70

$198.35

$219.16

2 Week Range

Now: $198.40

$174.20

$234.09

Volume

931,285 shs

Average Volume

745,511 shs

Market Capitalization

$16.69 billion

P/E Ratio

39.92

Dividend Yield

1.45%

Beta

1.01

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>